The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.
暂无分享,去创建一个
[1] C. Hack,et al. Time course of cytokine levels in sepsis , 1995, Intensive Care Medicine.
[2] Abraham,et al. Adjunctive therapy in sepsis : a critical analysis of the clinical trial programme , 2005 .
[3] Thomas R. Riley,et al. A Randomized Double-blind Placebo-controlled Trial , 2004 .
[4] Michael Bustin,et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. , 2003, Blood.
[5] José A Fernández,et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective , 2003, Nature Medicine.
[6] W. Aird,et al. Thrombin Stimulation of Vascular Adhesion Molecule-1 in Endothelial Cells Is Mediated by Protein Kinase C (PKC)-δ-NF-κB and PKC-ζ-GATA Signaling Pathways* , 2003, The Journal of Biological Chemistry.
[7] W. Aird,et al. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. , 2003, The Journal of biological chemistry.
[8] Charles Natanson,et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. , 2002, American journal of respiratory and critical care medicine.
[9] K. Isobe,et al. Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. , 2002, The American journal of pathology.
[10] E. Abraham,et al. Does blocking cytokines in sepsis work? , 2002, American journal of respiratory and critical care medicine.
[11] Yuji Saito,et al. Fluid Shear Stress Attenuates Hydrogen Peroxide–Induced c-Jun NH2-Terminal Kinase Activation via a Glutathione Reductase–Mediated Mechanism , 2002, Circulation research.
[12] John D Lambris,et al. Protection of innate immunity by C5aR antagonist in septic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] F. Gruber,et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage , 2002, Nature.
[14] C. Esmon. New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins , 2002, The Journal of experimental medicine.
[15] P. Hellings,et al. The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways , 2002, The Journal of experimental medicine.
[16] A. Malhotra,et al. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[17] M. Hottiger,et al. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders , 2002, Cellular and Molecular Life Sciences CMLS.
[18] D. Annane,et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.
[19] B. Lämmle,et al. C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction , 2002, Critical care medicine.
[20] J. Hamilton,et al. GM-CSF in inflammation and autoimmunity. , 2002, Trends in immunology.
[21] M. Weller,et al. Proteasome inhibition leads to NF‐κB‐independent IL‐8 transactivation in human endothelial cells through induction of AP‐1 , 2002, European journal of immunology.
[22] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[23] K. Triantafilou,et al. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. , 2002, Trends in immunology.
[24] A. Staubitz,et al. Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. , 2002, Blood.
[25] R. Frey,et al. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. , 2002, Circulation research.
[26] D. McCormack,et al. Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. , 2002, American journal of respiratory and critical care medicine.
[27] S. Coughlin,et al. Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[28] J. Harlan,et al. Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy , 2002, Critical care medicine.
[29] W. Aird. Endothelial cell dynamics and complexity theory , 2002, Critical care medicine.
[30] D. Golenbock,et al. Innate immune recognition of lipopolysaccharide by endothelial cells , 2002, Critical care medicine.
[31] R. Hotchkiss,et al. Endothelial cell apoptosis in sepsis , 2002, Critical care medicine.
[32] A. Schmaier,et al. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. , 2002, The American journal of pathology.
[33] S. Opal,et al. Antithrombin, heparin, and heparan sulfate , 2002, Critical care medicine.
[34] G. Zimmerman,et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis , 2002, Critical care medicine.
[35] J. Chiche,et al. The era of genomics: Impact on sepsis clinical trial design , 2002, Critical care medicine.
[36] T. van der Poll,et al. Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia1 , 2002, The Journal of Immunology.
[37] A. Schmaier. The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. , 2002, The Journal of clinical investigation.
[38] T. Štefanec. The effects of statins on mortality rates among bacteremic patients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] J. Bernhagen,et al. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. , 2002, Microbes and infection.
[40] C. Ruppert,et al. Cell-Specific Nitric Oxide Synthase-Isoenzyme Expression and Regulation in Response to Endotoxin in Intact Rat Lungs , 2002, Laboratory Investigation.
[41] M. Nishimura,et al. Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. , 2002, Blood.
[42] L. Medved,et al. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. , 2002, Biochemistry.
[43] D. Granger,et al. Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. , 2002, American journal of physiology. Heart and circulatory physiology.
[44] S. Opal,et al. Bench-to-bedside review: Toll-like receptors and their role in septic shock , 2002, Critical care.
[45] D. Bullard,et al. Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitis. , 2002, Experimental and molecular pathology.
[46] J. Carcillo,et al. The Tissue Factor and Plasminogen Activator Inhibitor Type-1 Response in Pediatric Sepsis-induced Multiple Organ Failure , 2002, Thrombosis and Haemostasis.
[47] R. Codoceo,et al. Interleukin‐1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis , 2002, Clinical and Experimental Immunology.
[48] S. Nadel. Helping to understand studies examining genetic susceptibility to sepsis , 2002, Clinical and experimental immunology.
[49] K. Jones,et al. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. , 2002, American journal of respiratory and critical care medicine.
[50] R. Bucala,et al. Macrophage migration inhibitory factor. , 2002, Critical care medicine.
[51] K. Zibara,et al. Acute Hyperglycaemia Induces Changes in the Transcription Levels of 4 Major Genes in Human Endothelial Cells: Macroarrays-based Expression Analysis , 2002, Thrombosis and Haemostasis.
[52] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[53] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[54] E Peterson,et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. , 2018, The New England journal of medicine.
[55] W. Aird,et al. Thrombin Stimulation of the Vascular Cell Adhesion Molecule-1 Promoter in Endothelial Cells Is Mediated by Tandem Nuclear Factor-κB and GATA Motifs* , 2001, The Journal of Biological Chemistry.
[56] M. Levi. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. , 2001, Journal of critical care.
[57] K. Tracey,et al. HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.
[58] M. Carraway,et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. , 2001, American journal of respiratory and critical care medicine.
[59] S. Zakynthinos,et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock , 2001, Intensive Care Medicine.
[60] S. Liu,et al. Lipopolysaccharide regulates constitutive and inducible transcription factor activities differentially in vivo in the rat. , 2001, Biochemical and biophysical research communications.
[61] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[62] G. Bernard,et al. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis , 2001, Critical care medicine.
[63] R. Postier,et al. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study , 2001, Critical care medicine.
[64] W. Aird,et al. NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. , 2001, American journal of physiology. Cell physiology.
[65] Ruslan Medzhitov,et al. Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.
[66] S. Stavchansky,et al. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. , 2001, American journal of physiology. Cell physiology.
[67] Juan F. García,et al. Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway , 2001 .
[68] S. Opal,et al. High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .
[69] J. Marshall,et al. Continuing challenges of sepsis research. , 2001, JAMA.
[70] A. Malik,et al. Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[71] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[72] W. Hancock,et al. Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.
[73] M. Fink. Prostaglandins and sepsis: still a fascinating topic despite almost 40 years of research. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[74] J. Helterbrand,et al. Low levels of protein C are associated with poor outcome in severe sepsis. , 2001, Chest.
[75] Jeffrey I. Weitz,et al. Characterization of a Mouse Model for Thrombomodulin Deficiency , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[76] L. Platanias,et al. Protein Kinase C-δ Regulates Thrombin-Induced ICAM-1 Gene Expression in Endothelial Cells via Activation of p38 Mitogen-Activated Protein Kinase , 2001, Molecular and Cellular Biology.
[77] W. Sessa,et al. Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[78] C. Esmon,et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. , 2001, The New England journal of medicine.
[79] C. Bradley. Steroids in sepsis--more effective than activated protein C? , 2001, Intensive & critical care nursing.
[80] L. Moldawer,et al. SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.
[81] M. Su,et al. The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. , 2001, Blood.
[82] T. Wirth,et al. Activation of NF-κB via the IκB Kinase Complex Is Both Essential and Sufficient for Proinflammatory Gene Expression in Primary Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[83] B. Vallet,et al. Endothelial cell dysfunction and coagulation , 2001, Critical care medicine.
[84] B. Grinnell,et al. Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis , 2001, Critical care medicine.
[85] W. Aird. Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis , 2001, Critical care medicine.
[86] C. Esmon. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation , 2001, Critical care medicine.
[87] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[88] R. Parker. IIb/IIIa or not IIb/IIIa, that is adhesion. , 2001, Critical care medicine.
[89] R. Bordet,et al. Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock , 2001, Critical care medicine.
[90] T. Kodama,et al. Function of GATA Transcription Factors in Induction of Endothelial Vascular Cell Adhesion Molecule-1 by Tumor Necrosis Factor-&agr; , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[91] B. Berk,et al. Fluid shear stress inhibits TNF-α activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[92] L. Gelbert,et al. Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.
[93] G. Guyatt,et al. New strategies for clinical trials in patients with sepsis and septic shock , 2001, Critical care medicine.
[94] R. Hofer-Warbinek,et al. Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. , 2001, Blood.
[95] T. van der Poll,et al. IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans1 , 2001, The Journal of Immunology.
[96] D. Lidington,et al. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. , 2001, Journal of applied physiology.
[97] T. Libermann,et al. ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene* , 2001, The Journal of Biological Chemistry.
[98] A. Medvedev,et al. Bacterial Lipopolysaccharide and IFN-γ Induce Toll-Like Receptor 2 and Toll-Like Receptor 4 Expression in Human Endothelial Cells: Role of NF-κB Activation1 , 2001, The Journal of Immunology.
[99] M. Quintel,et al. N-Acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients , 2001, Critical care medicine.
[100] W. Sibbald,et al. Endothelial E- and P-selectin expression in iNOS- deficient mice exposed to polymicrobial sepsis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[101] J. Pugin,et al. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. , 2001, American journal of respiratory and critical care medicine.
[102] S. Poole,et al. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood , 2001, Critical care medicine.
[103] N. Christou,et al. Soluble L-selectin at levels present in septic patients diminishes leukocyte-endothelial cell interactions in mice in vivo: A mechanism for decreased leukocyte delivery to remote sites in sepsis , 2001, Critical care medicine.
[104] T. van der Poll,et al. p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo , 2001, The Journal of Immunology.
[105] D. Perry,et al. Acquired antithrombin deficiency in sepsis , 2001, British journal of haematology.
[106] 岡本 育. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture , 2001 .
[107] A. Durán,et al. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. , 2001, Molecular cell.
[108] L. Platanias,et al. Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. , 2001, Molecular and cellular biology.
[109] T. Wirth,et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. , 2001, The Journal of biological chemistry.
[110] A. Medvedev,et al. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. , 2001, Journal of immunology.
[111] I. Singh,et al. Exposure to febrile temperature modifies endothelial cell response to tumor necrosis factor-alpha. , 2001, Journal of applied physiology.
[112] J. Helterbrand,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .
[113] S. Opal,et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. , 2001, JAMA.
[114] A. Malik,et al. Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice. , 2000, Physiological genomics.
[115] Nigel Mackman,et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.
[116] D. Bernstein,et al. Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.
[117] FrançoiseBono,et al. Factor Xa Activates Endothelial Cells by a Receptor Cascade Between EPR-1 and PAR-2 , 2000 .
[118] R. Bordet,et al. Effect of L-arginine on endothelial injury and hemostasis in rabbit endotoxin shock. , 2000, Journal of applied physiology.
[119] E. Weitzberg,et al. The endothelin system in septic and endotoxin shock. , 2000, European journal of pharmacology.
[120] A. Malik,et al. Protein kinase C-ζ mediates TNF-α-induced ICAM-1 gene transcription in endothelial cells , 2000 .
[121] S. Coughlin,et al. Thrombin signalling and protease-activated receptors , 2000, Nature.
[122] A. Malik,et al. Mechanisms regulating endothelial cell barrier function. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[123] A. Goldberg,et al. Inhibition of ubiquitin-proteasome pathway–mediated IκBα degradation by a naturally occurring antibacterial peptide , 2000 .
[124] K. Kuwano,et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. , 2000, The American journal of pathology.
[125] A. Abidia. Endothelial Cell Responses To Hypoxic Stress , 2000, Clinical and experimental pharmacology & physiology.
[126] Y. Ogura,et al. Interactions between blood cells and retinal endothelium in endotoxic sepsis. , 2000, Hypertension.
[127] R. de Caterina,et al. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. , 2000, Circulation research.
[128] J. Marshall. Complexity, chaos, and incomprehensibility: parsing the biology of critical illness. , 2000, Critical care medicine.
[129] A. Seely,et al. Multiple organ dysfunction syndrome: Exploring the paradigm of complex nonlinear systems , 2000, Critical care medicine.
[130] T. Kodama,et al. A novel cell adhesion inhibitor, K-7174, reduces the endothelial VCAM-1 induction by inflammatory cytokines, acting through the regulation of GATA. , 2000, Biochemical and biophysical research communications.
[131] J. Remacle,et al. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. , 2000, Biochimica et biophysica acta.
[132] P. Neumann,et al. Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α , 2000 .
[133] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[134] M. Suematsu,et al. Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo. , 2000, Circulation research.
[135] Y. Taniyama,et al. Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-κB (NF-κB)–Mediated bcl-2 Suppression In Vivo Evidence of the Importance of NF-κB in Endothelial Cell Regulation , 2000 .
[136] S. Coughlin,et al. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[137] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[138] W. Kox,et al. Endothelium function in sepsis , 2000, Inflammation Research.
[139] D. Granger,et al. Role of endotoxin in the expression of endothelial selectins after cecal ligation and perforation. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[140] W. V. Berghe,et al. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[141] J. A. Kruse,et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. , 2000, JAMA.
[142] T. Štefanec. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? , 2000, Chest.
[143] C. Wollheim,et al. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[144] J. Hansen,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Lepirudin blunts endotoxin-induced coagulation activation , 2022 .
[145] K. Hirata,et al. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. , 2000, Circulation.
[146] S. Nakamura,et al. Neutrophils express tissue factor in a monkey model of sepsis. , 2000, Surgery.
[147] A. Zeiher,et al. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[148] 山下 智也. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase , 2000 .
[149] W. Aird,et al. The endothelium and thrombosis. , 2000, Seminars in thrombosis and hemostasis.
[150] A. Goldberg,et al. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. , 2000, The Journal of clinical investigation.
[151] P. Neumann,et al. Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[152] A. Malik,et al. Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells. , 2000, American journal of physiology. Cell physiology.
[153] Y. Taniyama,et al. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. , 2000, Circulation research.
[154] M. Pinsky. Immune balance in critically ill patients. , 2000, Archivum immunologiae et therapiae experimentalis.
[155] J. Marshall,et al. Clinical trials of mediator-directed therapy in sepsis: what have we learned? , 2000, Intensive Care Medicine.
[156] A. Karsan,et al. NF-κB Activation Is Required for Human Endothelial Survival during Exposure to Tumor Necrosis Factor-α but Not to Interleukin-1β or Lipopolysaccharide* , 1999, The Journal of Biological Chemistry.
[157] T. Yokochi,et al. Complement-Dependent Accumulation and Degradation of Platelets in the Lung and Liver Induced by Injection of Lipopolysaccharides , 1999, Infection and Immunity.
[158] Z. Brown,et al. p38 MAPK signalling cascades in inflammatory disease. , 1999, Molecular medicine today.
[159] N. Prats,et al. Expression of E-selectin, P-selectin, and intercellular adhesion molecule-1 during experimental murine listeriosis. , 1999, The American journal of pathology.
[160] S. Coughlin,et al. How the protease thrombin talks to cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[161] A. Malik,et al. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. , 1999, Circulation.
[162] N. Tsopanoglou,et al. On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.
[163] R. Andriantsitohaina,et al. Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.
[164] X. Q. Zhang,et al. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. , 1999, Journal of immunology.
[165] M. Hibberd,et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease , 1999, The Lancet.
[166] J. Dhainaut,et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.
[167] Anand Kumar,et al. Genetic factors in septic shock. , 1999, JAMA.
[168] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[169] P. Ward,et al. Protective effects of C5a blockade in sepsis , 1999, Nature Medicine.
[170] G. Grau,et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.
[171] C. H. Lin,et al. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. , 1999, Circulation.
[172] S. Deventer,et al. CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS , 1999 .
[173] V. Briner,et al. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. , 1999, Kidney international.
[174] M. Gaestel,et al. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis , 1999, Nature Cell Biology.
[175] J. Harlan,et al. HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Endothelial Cells Undergoing Apoptosis Become Proadhesive for Nonactivated Platelets , 1999 .
[176] W. Aird,et al. Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.
[177] H. Hamm,et al. Thrombin Induces Proteinase-activated Receptor-1 Gene Expression in Endothelial Cells via Activation of Gi-linked Ras/Mitogen-activated Protein Kinase Pathway* , 1999, The Journal of Biological Chemistry.
[178] A. Malik,et al. Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. , 1999, Journal of immunology.
[179] J. Carlet. From mega to more reasonable doses of corticosteroids: a decade to recreate hope. , 1999, Critical care medicine.
[180] M. Rothe,et al. Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.
[181] A. Karsan,et al. Mechanisms of Hypoxia-induced Endothelial Cell Death , 1999, The Journal of Biological Chemistry.
[182] R. Giebler,et al. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. , 1999, Critical care medicine.
[183] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[184] H. Bruining,et al. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. , 1999, Circulation.
[185] M. Gaestel,et al. Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1, 94-97 , 1999 .
[186] A. Karsan,et al. NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide. , 1999, The Journal of biological chemistry.
[187] T. van der Poll,et al. Cytokines and anticytokines in the pathogenesis of sepsis. , 1999, Infectious disease clinics of North America.
[188] M. Gaestel,et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. , 1999, Nature cell biology.
[189] A. Sagripanti,et al. Tissue factor pathway inhibitor. , 1999, Minerva medica.
[190] S. Goldblum,et al. Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity and Survival Signaling Events through Caspase Cleavage of Adherens Junction Proteins* , 1998, The Journal of Biological Chemistry.
[191] M. Schaller,et al. Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. , 1998, Critical care medicine.
[192] C. Natanson,et al. The sirens' songs of confirmatory sepsis trials: selection bias and sampling error. , 1998, Critical care medicine.
[193] K. Kuwano,et al. Endothelial Cell Apoptosis in Lipopolysaccharide–Induced Lung Injury in Mice , 1998, International Archives of Allergy and Immunology.
[194] A. Harken,et al. THERAPEUTIC IMPLICATIONS OF INTERLEUKIN‐10 IN SURGICAL DISEASE , 1998, Shock.
[195] S. Gerondakis,et al. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. , 1998, The Journal of clinical investigation.
[196] A. Karsan,et al. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. , 1998, Blood.
[197] P. Carmeliet,et al. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. , 1998, The Journal of clinical investigation.
[198] J. Pouysségur,et al. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. , 1998, Molecular biology of the cell.
[199] A. Karsan,et al. Lipopolysaccharide Mediates Endothelial Apoptosis by a FADD-dependent Pathway* , 1998, The Journal of Biological Chemistry.
[200] J. Loscalzo,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.
[201] H. Rayburn,et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. , 1998, The Journal of clinical investigation.
[202] B. Berk,et al. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[203] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.
[204] R. Colman. The contact system: A proinflammatory pathway with antithrombotic activity , 1998, Nature Medicine.
[205] R. Medford,et al. Role of Activating Protein-1 in the Regulation of the Vascular Cell Adhesion Molecule-1 Gene Expression by Tumor Necrosis Factor-α* , 1998, The Journal of Biological Chemistry.
[206] R. Hynes,et al. Platelet-endothelial interactions in inflamed mesenteric venules. , 1998, Blood.
[207] J. Harlan,et al. Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα , 1998, The Journal of experimental medicine.
[208] S. Gullans,et al. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1beta-dependent paracrine loop. , 1998, The American journal of pathology.
[209] B. Schwippert,et al. Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species , 1998, Diabetologia.
[210] C. Hack,et al. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. , 1998, Journal of immunology.
[211] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.
[212] B. Alving,et al. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy. , 1998, Seminars in thrombosis and hemostasis.
[213] B. Schwippert,et al. Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. , 1998, Diabetologia.
[214] M. Vervloet,et al. Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic Shock , 1998, Seminars in thrombosis and hemostasis.
[215] W. Lynn. Anti-endotoxin therapeutic options for the treatment of sepsis. , 1998, The Journal of antimicrobial chemotherapy.
[216] M. Lamy,et al. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. , 1998, Intensive care medicine.
[217] P. Bongrand,et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). , 1998, Blood.
[218] M. Fink,et al. Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. , 1998, The Journal of antimicrobial chemotherapy.
[219] L. Aiuto,et al. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. , 1998, Critical care medicine.
[220] C. Cordon-Cardo,et al. Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation , 1997, The Journal of experimental medicine.
[221] D. Kreutzer,et al. Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. , 1997, Blood.
[222] A. Beaudet,et al. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. , 1997, The Journal of clinical investigation.
[223] Jean-PierreCazenave,et al. Thrombin Receptor-Mediated Increase of Two Matrix Metalloproteinases, MMP-1 and MMP-3, in Human Endothelial Cells , 1997 .
[224] C. Ferran,et al. Protective genes expressed in endothelial cells: a regulatory response to injury. , 1997, Immunology today.
[225] C. Orvain,et al. Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[226] D. Männel,et al. Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.
[227] S. Cuzzocrea,et al. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. , 1997, The Journal of clinical investigation.
[228] M. Marino,et al. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. , 1997, Journal of immunology.
[229] R. Bone,et al. Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.
[230] S. Opal,et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.
[231] C. Natanson,et al. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. , 1997, Critical care medicine.
[232] T. Huizinga,et al. Genetic influence on cytokine production in meningococcal disease , 1997, The Lancet.
[233] P. Bongrand,et al. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. , 1997, Journal of immunology.
[234] R. Jordan,et al. 7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli. , 1997, Blood.
[235] P. Neumann,et al. Endothelial barrier dysfunction and p42 oxidation induced by TNF-alpha are mediated by nitric oxide. , 1997, The American journal of physiology.
[236] G. Parry,et al. Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1 , 1997, European journal of immunology.
[237] A. Karsan,et al. Apoptotic vascular endothelial cells become procoagulant , 1997 .
[238] G. Bernard,et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.
[239] E. Holler,et al. Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. , 1997, Blood.
[240] A. Haeberli,et al. Anticoagulant Properties of the Vascular Endothelium , 1997, Thrombosis and Haemostasis.
[241] M. Lamy,et al. Sepsis and serum cytokine concentrations. , 1997, Critical care medicine.
[242] T. Tanaka,et al. The role of neutrophil elastase in human pulmonary artery endothelial cell injury. , 1997, International archives of allergy and immunology.
[243] M. Gerritsen,et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. , 1997, Journal of immunology.
[244] E. Jaffe,et al. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. , 1997, Blood.
[245] T. van der Poll,et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. , 1997, Journal of immunology.
[246] W. Knaus,et al. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group. , 1997, JAMA.
[247] M. Kastan,et al. Role of p53 in apoptosis. , 1997, Advances in pharmacology.
[248] C. Haslett,et al. Modulation of human endothelial thrombomodulin by neutrophils and their release products. , 1997, American journal of respiratory and critical care medicine.
[249] M. Nehls,et al. Shear stress inhibits apoptosis of human endothelial cells , 1996, FEBS letters.
[250] Y. Endo,et al. Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock , 1996, Infection and immunity.
[251] D E Griswold,et al. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. , 1996, The Journal of pharmacology and experimental therapeutics.
[252] H. S. Kim,et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[253] R. McCuskey,et al. The microcirculation during endotoxemia. , 1996, Cardiovascular research.
[254] P. Tsao,et al. Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. , 1996, Circulation.
[255] M. Labow,et al. Heterogeneity of expression of E- and P-selectins in vivo. , 1996, Circulation research.
[256] J. Carlet,et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. , 1996, Critical care medicine.
[257] I. Adcock,et al. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. , 1996, Critical care medicine.
[258] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[259] S. Opal,et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.
[260] D. Loskutoff,et al. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. , 1996, The Journal of clinical investigation.
[261] K. Murakami,et al. Thrombin stimulates production of interleukin‐8 in human umbilical vein endothelial cells , 1996, Immunology.
[262] R. Colman,et al. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. , 1996, Blood.
[263] A. Manning,et al. Regional differences in constitutive and induced ICAM-1 expression in vivo. , 1995, The American journal of physiology.
[264] A. Hoffbrand,et al. Induction of tissue factor expression in human monocyte/endothelium cocultures , 1995, British journal of haematology.
[265] O. Smithies,et al. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[266] W. Waldhäusl,et al. High-Glucose–Triggered Apoptosis in Cultured Endothelial Cells , 1995, Diabetes.
[267] E. Connolly,et al. Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. , 1995, Seminars in cell biology.
[268] François Gouin,et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .
[269] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[270] Craig R. Smith,et al. Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial , 1995 .
[271] D. Cook,et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. , 1995, Critical care medicine.
[272] R. C. Johnson,et al. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[273] G. Broze,et al. Tissue Factor Pathway Inhibitor , 1995, Thrombosis and Haemostasis.
[274] J. Røttingen,et al. Binding of Human Factor VIIa to Tissue Factor Induces Cytosolic Ca2+ Signals in J82 Cells, Transfected COS-1 Cells, Madin-Darby Canine Kidney Cells and in Human Endothelial Cells Induced to Synthesize Tissue Factor (*) , 1995, The Journal of Biological Chemistry.
[275] T. van der Poll,et al. Complete Inhibition of Endotoxin-Induced Coagulation Activation in Chimpanzees with a Monoclonal Fab Fragment against Factor VII/VIIa , 1995, Thrombosis and Haemostasis.
[276] D. Pittet,et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.
[277] C. Thiemermann,et al. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[278] M. Peterson,et al. Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein Synthesis , 1994 .
[279] K. Kaji,et al. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. , 1994, Journal of biochemistry.
[280] S. Lowry,et al. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. , 1994, Circulatory shock.
[281] Craig R. Smith,et al. Treatment of Septic Shock with Human Monoclonal Antibody HA-1A , 1994, Annals of Internal Medicine.
[282] A. Mantovani,et al. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. , 1994, The American journal of pathology.
[283] M. Peterson,et al. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. , 1994, Experimental cell research.
[284] J. Dhainaut,et al. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. , 1994, Critical care medicine.
[285] M. Levi,et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. , 1993, The Journal of clinical investigation.
[286] P. Ward,et al. Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1 , 1993 .
[287] A. Chang,et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. , 1993, The Journal of clinical investigation.
[288] T. Drake,et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. , 1993, The American journal of pathology.
[289] X. Ding,et al. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. , 1993, The American journal of physiology.
[290] M. Howard,et al. Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.
[291] J. Vincent,et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.
[292] R. Colman,et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. , 1993, The Journal of clinical investigation.
[293] P. Ward,et al. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. , 1993, The American journal of pathology.
[294] A. Malik,et al. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion , 1992, The Journal of cell biology.
[295] C. Natanson,et al. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin , 1992, The Journal of experimental medicine.
[296] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[297] A. Malik,et al. Thrombin-Mediated Increase in Vascular Endothelial Permeability , 1992, Seminars in thrombosis and hemostasis.
[298] G. Zimmerman,et al. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils , 1991, The Journal of cell biology.
[299] G. Broze,et al. Factor XI activation in a revised model of blood coagulation , 1991, Science.
[300] C. Esmon,et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. , 1991, Blood.
[301] F. Taylor,et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. , 1991, Circulatory shock.
[302] H. ten Cate,et al. Factor IX is activated in vivo by the tissue factor mechanism. , 1990, Blood.
[303] Steven D. Carson,et al. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. , 1990, Blood.
[304] R. Rosenberg. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. , 1989, The American journal of medicine.
[305] T. Emerson,et al. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. , 1989, American Journal of Medicine.
[306] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[307] B. Meyrick,et al. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. , 1989, Journal of applied physiology.
[308] M. Gimbrone,et al. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.
[309] M. Gerritsen. Functional heterogeneity of vascular endothelial cells. , 1987, Biochemical pharmacology.
[310] A. Chang,et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.
[311] C. Esmon,et al. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. , 1987, The Journal of clinical investigation.
[312] W. Fiers,et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[313] G. Zimmerman,et al. Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. , 1985, Circulation.
[314] T. Flægstad,et al. Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis , 1983, Thrombosis and Haemostasis.
[315] B. Osterud,et al. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. , 1983, Thrombosis and haemostasis.
[316] H. Wolinsky. Circulation Research an Official Journal of the American Heart Association a Proposal Linking Clearance of Circulating Lipoproteins to Tissue Metabolic Activity as a Basis for Understanding Atherogenesis , 2022 .
[317] F. Taylor,et al. Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. , 1978, Circulatory shock.
[318] B. Osterud,et al. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[319] L. Díaz-Flores,et al. [Disseminated intravascular coagulation]. , 1977, Actas dermo-sifiliograficas.